Search research articles
Contact Us
Filters
Showing results (371-380 of 621) with videos related to
Page
of 63
Sort By:
Arthritis Research & Therapy
|
October 29, 2020
Health Assessment Questionnaire-Disability Index (HAQ-DI) use in modelling disease progression in diffuse cutaneous systemic sclerosis: an analysis from the EUSTAR database
Yannick Allanore, Sylvie Bozzi, Augustin Terlinden, et al.
RMD Open
|
February 3, 2022
Current differentiation between radiographic and non-radiographic axial spondyloarthritis is of limited benefit for prediction of important clinical outcomes: data from a large, prospective, observational cohort
Adrian Ciurea, Seraphina Kissling, Kristina Bürki, et al.
Communications Biology
|
February 24, 2023
Author Correction: The AP-1 transcription factor Fosl-2 drives cardiac fibrosis and arrhythmias under immunofibrotic conditions
Mara Stellato, Matthias Dewenter, Michal Rudnik, et al.
Communications Biology
|
February 9, 2023
The AP-1 transcription factor Fosl-2 drives cardiac fibrosis and arrhythmias under immunofibrotic conditions
Mara Stellato, Matthias Dewenter, Michal Rudnik, et al.
Swiss Medical Weekly
|
April 5, 2024
Therapeutic management of fibrosis in systemic sclerosis patients - an analysis from the Swiss EUSTAR cohort
Kevin Windirsch, Suzana Jordan, Mike Oliver Becker, et al.
Chest
|
October 16, 2022
Cohort Enrichment Strategies for Progressive Interstitial Lung Disease in Systemic Sclerosis From European Scleroderma Trials and Research
Anna-Maria Hoffmann-Vold, Cathrine Brunborg, Paolo Airò, et al.
Clinical and Experimental Rheumatology
|
July 29, 2021
A randomised, double-blind, placebo-controlled phase 3 study of lenabasum in diffuse cutaneous systemic sclerosis: RESOLVE-1 design and rationale
Robert Spiera, Dinesh Khanna, Masataka Kuwana, et al.
RMD Open
|
November 10, 2023
Sex-specific difference in cardiac function in patients with systemic sclerosis: association with cardiovascular outcomes
Tea Gegenava, Federico Fortuni, Nina Marijn van Leeuwen, et al.
Annals of the Rheumatic Diseases
|
December 11, 2019
Haemodynamic phenotypes and survival in patients with systemic sclerosis: the impact of the new definition of pulmonary arterial hypertension
Panagiota Xanthouli, Suzana Jordan, Nicklas Milde, et al.
British Journal of Pharmacology
|
July 7, 2020
Translational engagement of lysophosphatidic acid receptor 1 in skin fibrosis: from dermal fibroblasts of patients with scleroderma to tight skin 1 mouse
Laetitia Ledein, Bertrand Léger, Clara Dees, et al.
Page
of 63
Search research articles
Search
Showing results (371-380 of 621) with videos related to
Sort By:
Page
of 63
Arthritis Research & Therapy
|
October 29, 2020
Health Assessment Questionnaire-Disability Index (HAQ-DI) use in modelling disease progression in diffuse cutaneous systemic sclerosis: an analysis from the EUSTAR database
Yannick Allanore, Sylvie Bozzi, Augustin Terlinden, et al.
RMD Open
|
February 3, 2022
Current differentiation between radiographic and non-radiographic axial spondyloarthritis is of limited benefit for prediction of important clinical outcomes: data from a large, prospective, observational cohort
Adrian Ciurea, Seraphina Kissling, Kristina Bürki, et al.
Communications Biology
|
February 24, 2023
Author Correction: The AP-1 transcription factor Fosl-2 drives cardiac fibrosis and arrhythmias under immunofibrotic conditions
Mara Stellato, Matthias Dewenter, Michal Rudnik, et al.
Communications Biology
|
February 9, 2023
The AP-1 transcription factor Fosl-2 drives cardiac fibrosis and arrhythmias under immunofibrotic conditions
Mara Stellato, Matthias Dewenter, Michal Rudnik, et al.
Swiss Medical Weekly
|
April 5, 2024
Therapeutic management of fibrosis in systemic sclerosis patients - an analysis from the Swiss EUSTAR cohort
Kevin Windirsch, Suzana Jordan, Mike Oliver Becker, et al.
Chest
|
October 16, 2022
Cohort Enrichment Strategies for Progressive Interstitial Lung Disease in Systemic Sclerosis From European Scleroderma Trials and Research
Anna-Maria Hoffmann-Vold, Cathrine Brunborg, Paolo Airò, et al.
Clinical and Experimental Rheumatology
|
July 29, 2021
A randomised, double-blind, placebo-controlled phase 3 study of lenabasum in diffuse cutaneous systemic sclerosis: RESOLVE-1 design and rationale
Robert Spiera, Dinesh Khanna, Masataka Kuwana, et al.
RMD Open
|
November 10, 2023
Sex-specific difference in cardiac function in patients with systemic sclerosis: association with cardiovascular outcomes
Tea Gegenava, Federico Fortuni, Nina Marijn van Leeuwen, et al.
Annals of the Rheumatic Diseases
|
December 11, 2019
Haemodynamic phenotypes and survival in patients with systemic sclerosis: the impact of the new definition of pulmonary arterial hypertension
Panagiota Xanthouli, Suzana Jordan, Nicklas Milde, et al.
British Journal of Pharmacology
|
July 7, 2020
Translational engagement of lysophosphatidic acid receptor 1 in skin fibrosis: from dermal fibroblasts of patients with scleroderma to tight skin 1 mouse
Laetitia Ledein, Bertrand Léger, Clara Dees, et al.
Page
of 63